// App-Quantinova.ai

: Identification of mechanism-specific biomarkers to guide development of the lung-selective inhaled pan-JAK inhibitor TD-8236

Researchers

Presenter

  • Emma Gordon

Principal Investigators

  • Elad Kaufman

  • Reuben Sana

  • Alexander Mcnamara

  • Nathan Pfeifer

  • Edmund J. Moran

  • Glenn D. Crater

  • Melanie A. Kleinschek

  • Jacky Woo

  • Thomas Southworth

  • Thomas Scott

  • Dave Singh

Medical Centers

  • Theravance Biopharma US, Inc., South San Francisco, United States of America

  • University of Manchester, Medicines Evaluation Unit, Manchester, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Mucin 5AC

  • Granulocyte-macrophage-colony stimulating factor

  • Interleukin 13

  • Interleukin 6

  • Interferon-gamma

Drug/Treatment

  • GM-CSF

  • Interferon Gamma

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved